VREX

Varex Imaging Corporation NASDAQ

Healthcare ·Medical - Devices ·US · vareximaging.com

$11.61

After hrs $11.61 +0.00%

Mkt Cap $480.7M

52w Low $6.76 62.1% of range 52w High $14.56

50d MA $11.75 200d MA $11.59

P/E (TTM) -6.8x

EV/EBITDA 214.6x

P/B 1.0x

Debt/Equity 0.8x

ROE -14.2%

P/FCF 26.3x

RSI (14) —

ATR (14) —

Beta 1.00

50d MA $11.75

200d MA $11.59

Avg Volume 312.3K

About

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, col…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 10, 2026	AMC	0.14	0.19	+35.7%	14.15	-10.3%	-3.8%	-5.4%	-4.5%	-4.6%	-2.5%	-23.3%	—
Nov 18, 2025	AMC	0.18	0.37	+105.6%	11.86	-9.2%	-13.7%	-13.2%	-10.0%	-7.1%	-5.5%	+4.0%	—
Aug 7, 2025	AMC	0.04	0.18	+350.0%	7.81	+10.0%	+21.4%	+25.1%	+35.3%	+36.9%	+38.0%	+49.4%	—
May 8, 2025	AMC	0.14	0.26	+85.7%	8.65	-0.7%	-20.5%	-13.1%	-13.3%	-13.9%	-8.8%	-1.5%	—
Feb 6, 2025	AMC	0.04	0.07	+75.0%	15.20	-11.2%	-19.3%	-14.7%	-11.2%	-11.6%	-10.5%	-17.5%	—
Nov 19, 2024	AMC	0.09	0.19	+111.1%	14.56	+4.6%	+5.9%	+13.4%	+14.3%	+12.6%	+13.4%	-1.2%	—
Aug 1, 2024	AMC	0.19	0.14	-26.3%	14.27	-8.4%	-9.0%	-13.7%	-18.4%	-19.8%	-20.2%	-17.0%	—
May 2, 2024	AMC	0.23	0.16	-30.4%	16.43	-11.3%	-5.1%	-4.9%	-3.5%	-4.1%	-3.3%	-3.2%	—
Feb 6, 2024	AMC	0.11	0.06	-45.5%	19.44	-6.1%	-9.2%	-12.0%	-9.2%	-8.5%	-12.6%	-9.5%	—
Nov 14, 2023	AMC	0.33	0.45	+36.4%	19.41	-8.4%	-0.8%	-3.5%	-2.2%	-1.9%	+0.2%	+8.4%	—
Aug 1, 2023	AMC	0.33	0.37	+12.1%	23.01	-1.2%	-2.6%	-1.6%	-1.4%	-1.3%	-3.1%	-14.5%	—
May 2, 2023	AMC	0.17	0.26	+52.9%	17.27	+7.9%	+19.5%	+22.9%	+27.4%	+27.4%	+26.2%	+27.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Nov 19	B. Riley Securities	Maintains	Buy → Buy	—	$11.86	$10.77	-9.2%	-13.7%	-13.2%	-10.0%	-7.1%	-5.5%
Nov 19	Oppenheimer	Maintains	Outperform → Outperform	—	$11.86	$10.77	-9.2%	-13.7%	-13.2%	-10.0%	-7.1%	-5.5%
Aug 8	B. Riley Securities	Maintains	Buy → Buy	—	$7.81	$8.59	+10.0%	+21.4%	+25.1%	+35.3%	+36.9%	+38.0%
Feb 7	B. Riley Securities	Maintains	Buy → Buy	—	$15.20	$13.50	-11.2%	-19.3%	-14.7%	-11.2%	-11.6%	-10.5%
Feb 7	Oppenheimer	Maintains	Outperform → Outperform	—	$15.20	$13.50	-11.2%	-19.3%	-14.7%	-11.2%	-11.6%	-10.5%
Nov 15	Oppenheimer	Maintains	Outperform → Outperform	—	$19.41	$17.77	-8.4%	-0.8%	-3.5%	-2.2%	-1.9%	+0.2%
Aug 2	Oppenheimer	Maintains	Outperform → Outperform	—	$23.01	$22.74	-1.2%	-2.6%	-1.6%	-1.4%	-1.3%	-3.1%
May 24	Jefferies	Maintains	Hold → Hold	—	$21.69	$21.84	+0.7%	+0.6%	-0.5%	+0.3%	+0.9%	+1.6%
Oct 12	Jefferies	Maintains	Hold → Hold	—	$21.08	$20.85	-1.1%	-9.3%	-5.2%	-5.4%	-2.9%	-2.6%
Feb 5	Oppenheimer	Upgrade	Perform → Outperform	—	$19.89	$25.00	+25.7%	+17.9%	+18.4%	+15.2%	+12.4%	+16.9%
Aug 13	Oppenheimer	Downgrade	Outperform → Perform	—	$16.00	$13.10	-18.1%	-19.8%	-15.6%	-19.7%	-22.9%	-24.7%
May 13	Sidoti & Co.	Maintains	Buy → Buy	—	$25.32	$20.50	-19.0%	-32.6%	-26.4%	-30.8%	-26.1%	-29.7%
May 13	JP Morgan	Downgrade	Overweight → Neutral	—	$25.32	$20.50	-19.0%	-32.6%	-26.4%	-30.8%	-26.1%	-29.7%
May 13	Jefferies	Maintains	Hold → Hold	—	$25.32	$20.50	-19.0%	-32.6%	-26.4%	-30.8%	-26.1%	-29.7%
Mar 25	JP Morgan	Upgrade	Neutral → Overweight	—	$19.49	$20.66	+6.0%	+2.6%	+8.5%	+2.6%	+7.6%	+16.5%
Feb 12	Jefferies	Downgrade	Buy → Hold	—	$27.41	$24.00	-12.4%	-5.5%	-5.3%	-5.5%	-6.7%	-5.4%
Nov 13	JP Morgan	Maintains	Neutral → Neutral	—	$32.67	$33.00	+1.0%	-9.9%	-8.8%	-7.8%	-10.3%	-9.7%
Oct 22	Oppenheimer	Maintains	Outperform → Outperform	—	$29.14	$29.50	+1.2%	+0.1%	+1.5%	-1.6%	-0.3%	+1.8%
Mar 19	Northland Securities	Maintains	Outperform → Outperform	—	$32.94	$33.43	+1.5%	+4.0%	+3.1%	+3.5%	+1.5%	+1.5%
Nov 14	JP Morgan	Maintains	Neutral → Neutral	—	$26.11	$24.99	-4.3%	-6.0%	-4.1%	+0.7%	-1.8%	-7.0%
Dec 20	JP Morgan	Upgrade	Underweight → Neutral	—	$37.84	$38.00	+0.4%	+4.9%	+7.1%	+8.5%	+7.7%	+8.8%
Oct 4	JP Morgan	Downgrade	Neutral → Underweight	—	$34.59	$32.70	-5.5%	-3.6%	-4.5%	-4.1%	-4.6%	-4.4%
Aug 9	Jefferies	Maintains	Buy → Buy	—	$29.20	$29.39	+0.7%	-1.0%	-1.8%	-0.3%	+3.0%	+0.4%
Aug 8	JP Morgan	Upgrade	Underweight → Neutral	—	$28.27	$28.96	+2.4%	+3.3%	+2.2%	+1.4%	+3.0%	+6.4%
Apr 21	JP Morgan	Downgrade	Neutral → Underweight	—	$36.04	$34.74	-3.6%	-2.6%	-3.8%	-5.7%	-6.1%	-6.5%

Recent Filings

8-K · 1.01 !! High

Unknown — 8-K 1.01: Material Agreement

BMO and VREX secured significant credit facilities with subsidiary guarantees and standard covenants, potentially limiting financial flexibility but providing operational capital for growth or refinancing needs.

Mar 16

8-K

Varex Imaging Corporation -- 8-K Filing

I cannot provide a meaningful investment analysis from this filing summary, as it contains only technical metadata and schema references rather than substantive business information about Varex Imaging.

Feb 13

8-K

Varex Imaging Corporation -- 8-K Filing

Varex Imaging exceeded Q1FY26 guidance with $210 million revenue and $0.19 non-GAAP EPS, demonstrating solid operational performance despite $16 million negative operating cash flow.

Feb 10

Data updated apr 27, 2026 8:06am · Source: massive.com